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S6 Abstractsinfluenza virus (HPAIV) strain H5N1 has resulted in serious economic losses to the poultry industry, many countries including Vietnam have
introduced mass vaccination of poultry with H5N1 virus vaccines. We found that eggs obtained from chicken farms and supermarkets in Vietnam
contain H5N1-specific immunoglobulins (IgY) that provide protection against infections with HPAIV H5N1 and related H5N2 strains in mice.
When administered intranasally before or after lethal infection with HPAIV H5N1, H5N1-specific IgY prevent disease or significantly reduce viral
replication resulting in complete recovery from the disease, respectively. In addition, we generated H1N1 virusspecific IgY by immunization of hens
with inactivated H1N1 A/PR/8/34 as a model virus for current pandemic H1N1/09 and found that such H1N1-specific IgY protect mice from lethal
influenza virus infection.
These results underscore the usefulness of recombinant Ad vectors encoding surface glycoprotein (HA) and conserved protein (M2e) and NS1
deleted viruses (DelNS1) as vaccine candidates for control of pre-pandemic H5N1 and newly emerging subtypes. Data on antiviral efficacy of IgY
provide a proof-of-concept for the approach using virus-specific IgY as affordable, safe, and effective alternative for the control of influenza
outbreaks, including the potential H5N1 and current H1N1 pandemic.
doi:10.1016/j.phrp.2011.11.023
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In response to the global spread of the H1N1 influenza virus after first being detected in North America in April 2009, WHO declared the first
influenza pandemic in more than four decades on June 11 of the same year. In Korea, the arrival of the 2009 H1N1 pandemic influenza triggered an
integrated response that was mainly based on the 2006 Pandemic Influenza Preparedness and Response Plan. At least 270 fatal cases, 764
laboratory-thousand confirmed cases, and 3.6 million courses of antiviral agent use were reported to the end of August 2010 in this country. Even if
government tried to control and mitigate the impact of pandemic by using public health and medical countermeasures, there were several issues
found during the H1N1 pandemic responses. The main difficulty was the delayed and insufficient supply of pandemic vaccine. Therefore the mass
vaccination campaign was begun after the peak of pandemic and its mitigation effect on the pandemic disease burden was diminished. The amount
of stockpiled antiviral agents by government was not enough in the early phase of pandemic. The rapid antigen test for the H1N1 influenza showed
low sensitivity, about 50%. Many infected people were seeking to be diagnosed with rRT-PCR test, which is expensive and not useful for the
decision of antiviral use because of late test report. The communications among government, medical societies, general people and mass media were
also not satisfactory. Lessons learned from the national response to the H1N1 pandemic made the government to launch the TEPIK in October 2010.
TEPIK will incorporate those lessons into the future pandemic preparedness planning. The mission of TEPIK is to ensure the safety of the nation
and people from the threat of pandemic influenza. TEPIK focuses to establish government-academic-institute-industry collaborative system with
three main strategies; to expedite sharing of R&D information and preparation of national communication; to establish the preparedness and
response of R&D investment strategy for usual and pandemic phase; and to secure the innovative and leading response technology against pandemic
influenza. TEPIK has 34 research projects in eight research areas, which include vaccine; therapeutics; diagnostics; basic/mechanism; clinical/
policy; surveillance/epidemiology; innovative researches; and infrastructures. Research subjects in each research area will be stated in this
presentation.
doi:10.1016/j.phrp.2011.11.024
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Until 2000 when the Communicable Diseases Control Law was revised, influenza has been considered as one of the neglected disease in Korea. The
vaccine coverage was low and there were no reliable statistics about influenza. With the revision of the Law, influenza was grouped as group III
disease which needs surveillance and Korea Influenza Surveillance Scheme (KISS) was launched on September of 2000.
While the surveillance system has been established and improved with following seasons, diagnosis and related research has been diversified and
intensified. With the successive outbreak of SARS and avian influenza outbreaks from 2003, 2006, 2008 and 2010, diagnosis of influenza has been
improved by the introduction of genetic detection from RT-PCR to multiplex RT-PCR. During the 2009 pandemic we introduced the multiplex
realtime RT-PCR and it is being used now which can differentiate seasonal influenza (H1, H3 and B), A(H1N1)pdm09, and H5. For the serological
diagnosis, conventional hemagglutination inhibition and microneutralization has been established with standardization for each virus using various
red blood cell or variation of HA antigen preparation. Also to minimize the possible infection by highly pathogenic avian influenza virus (HPAIV),
microneutralization using pseudotype virus with appropriate HA gene of HPAIV has been developed.
Also with the increased the need for molecular analysis based on sequence, Influenza Sequence and Epitope Database (ISED) was developed in
2008 and expanded the contents from seasonal influenza to avian influenza with various hosts. The result of genetic characterization to detect the
variation in antigenic sites and antiviral drugs resistance has been widely used for the surveillance and also for the treatment of influenza patients
since the worldwide spread of drug resistant virus.
Abstracts S7With the outbreak of novel 2009 pandemic virus, the diagnosis and the characterization of the first case in Korea was completed within a week and
several research projects were immediately launched in the diagnosis, vaccine development, and pathogenicity study using the influenza A/Korea/01/
2009(H1N1) virus. Especially for 2009 pandemic virus,mammalian pathotyping usingmouse and ferret has been performed in BSL-3 facility inKNIH.
Prepandemic period was the preparatory for capacity building for intensified influenza research in KNIH. In post pandemic period, research field
will be more focused on vaccine and pathogenesis of influenza in human based on the strong infrastructure built through previous research products
as well as capacity building in diagnosis and surveillance to detect new influenza virus in humans.
doi:10.1016/j.phrp.2011.11.025
Climate Change and Malaria Transmission in Thailand
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Climate warming can change the geographic distribution and intensity of the transmission of vector-borne diseases such as malaria.
The heterogeneity in malaria trends probably reflects the multitude of factors that can drive malaria transmission. There are studies of climate
change that probably alter the spread and transmission intensity of malaria in Africa.
The transmitted parasites usually benefit from increased temperatures as both their reproduction and development are accelerated. These finding
suggest that the abundance, distribution and malaria transmission of different malaria vectors are driven by different environmental factors.
Malaria transmission and climate changes in high and low endemic areas in Thailand will be discussed.
A better understanding of the specific ecological parameters of each malaria mosquito species will help define their current distributions, and how
they may currently and prospectively be affected by climate change, interventions and other factors.
doi:10.1016/j.phrp.2011.11.026
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Asian tiger mosquito, Aedes albopictus, is one of vectors of the dengue and Chikungunya viruses and was common mosquitoes in Southeast Asia,
Far East including Japan. During past two decades the distribution areas of Ae. albopictus clearly expand to worldwide by world trading of used
tiers. In Japan Aedes albopictus distributed widely in Honshu Island of Japan with its northern limits between 38 to 40 degrees north. The factors
affecting distribution of the species in Japan were studied using the GIS and showed an annual mean temperature higher than 11 Co is most related
to the northern limit. During 1998e2006, larval surveillance was carried out in more than 30 urban and rural areas in Tohoku district, the northern
limit clearly moved to northward. The future expansion of the distribution of Ae. albopictus were analyzed using 1-km mesh climate data prospected
by MIROC(K1) model in 2035 and 2100. From these analyses, the distribution of the mosquitoes widely expands in the lowland areas of Aomori
Prefecture, most northern Honshu district in 2035. Ae. albopictus will also invade to Hokkaido Island crossing the Tsugaru Strait in 2100. This
means that risk areas in dengue and Chikungunya outbreak clearly expand in the northern parts of Japan. The population density of the mosquito is
one of the important factors to predict the possibility of outbreak of mosquito borne diseases. Ae. albopictus is not a simple nuisance mosquito, so
we should recognize the importance of this mosquito species as an important vector of viral diseases, dengue and chikungunya. The technical report
published by ECDC in 2009 entitled “Development of Aedes albopictus risk map” completely adopted our criterion, 11 Co as a northern expansion
limit in Europe and North America.
doi:10.1016/j.phrp.2011.11.027
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As management measures for vector borne diseases, vector surveillance system and vector control system are created with management of
infectious diseases such as malaria, Japanese encephalitis and scrub typhus.
Surveillance for disease vectors
Malaria vector surveillance is conducted by collecting from 16 sites around malaria risk areas where the disease occurs. The seasonal population
density of vector mosquitoes and infection rate of Plasmodium are conducted. Japanese encephalitis vector surveillance is the oldest vector
surveillance system in Korea. It is currently being conducted at 39 sites nationwide, and it provides the precautionary attention at first appearance date
